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ABSTRACT 
Aims  
The aims of these studies were to explore the prevalence and severity of depression 
among unscheduled drop-in patients in primary care and to identify possible cues to 
depression in the consultation. Further aims were to analyse the association between 
depression and psychosocial stressors and lifestyle factors from a gender perspective 
and to evaluate the usefulness of the Gotland Male Depression Scale (GS) in screening 
for depression among men. A final aim was to analyse the long-term mortality rate 
(MR) and the standardised mortality rate (SMR) among the patients who had been 
diagnosed as having a major depressive disorder (MDD). 
 
Background  
Depression is a common diagnosis in primary care, but had been reported to remain 
undetected in half of the consultations, especially among men despite the fact that men 
had higher rates of suicide. Detecting and diagnosing patients with depression in 
primary care is essential since depression reduces quality of life, functioning level, 
work ability and possibly also life expectancy. 
 
Patients and Methods  
Patients visiting two primary care physicians’ drop-in clinics were screened using the 
Beck Depression Inventory (BDI) with a cut-off value of ≥ 10 and the men were 
screened also with the GS with a cut-off value of ≥ 13. A two-step screening method 
was used among patients aged 18–75 years visiting two primary care physicians’ drop-
in clinics in opportunistic and targeted screenings. Patients with screening scores above 
the cut-off values were interviewed by the physicians at a repeat visit by applying the 
DSM-IV criteria for major depressive disorder (MDD). Severity of depression was 
measured with the Montgomery-Åsberg Depression Rating Scale (MADRS). 
The study population consisted of 404 patients (men n=235, women n=169) categorised 
as depressed (n=124) or non-depressed (n= 280). 
Their socio-demographic data, lifestyle and psychosocial stressors were obtained from 
a questionnaire. Symptoms mentioned at the screening visit were examined from the 
medical charts and categorised as somatic or mental. 
Twelve years after inclusion, the causes of death for the depressed patients were 
obtained from the National Cause of Death Register. Mortality data regarding the non-
depressed patients were obtained from the Swedish National Register and data from the 
Life Tables Statistics Sweden were used to calculate standardised mortality rates 
(SMRs). 
The screenings among men with GS and BDI were compared, as were the outcomes 
from the opportunistic and targeted screenings. Differences between depressed and 
non-depressed men and women regarding socio-demographic and clinical data were 
analysed. The odds ratios (ORs) with 95% confidence intervals (95% CI) for being 
depressed were calculated for the psychosocial stressors and lifestyle factors. Multiple 
logistic regression modelling was used to obtain the main effect models separately for 
men and women for the risk factors for depression.  
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Differences in the MRs between the depressed and the non-depressed patients were 
calculated as well as their SMRs. As a reference for comparison the SMRs in the 
Swedish population in the same age and in the same time period were calculated.  
Cox regression was applied to calculate the hazard ratios (HRs) for the mortality 
rate during the 12-year follow-up period for the depressed and the non-depressed 
patients in relation to the explanatory variables. 
 
Main results  
The prevalence of depression was 25% among women and 11% among men. The 
severity of depression was mild or moderate and severe depression was very rare. 
Mentioning a mental symptom was a cue to detect depression among women but not 
consistently among men. The proportions as depressed patients were higher from the 
targeted screenings than from the opportunistic screenings. Screening with GS did not 
detect more depressed men than BDI. 
Smoking was associated with depression only among men. Three psychosocial 
stressors were equally associated with depression among the men and the women: 
being dissatisfied with family situation, being very stressed and perceiving poor 
physical health, and the ORs in the main effect models varied from 3.1 (95% CI 1.4–
6.6) up to 22.4 (95% CI 5.8–86.8). Dissatisfaction with one’s working situation was 
also associated with depression: in men OR 13.2 (95% CI 4.7–37.5) and in women: OR 
32.5 (95% CI 4.1–254.7). The MR among the depressed men was significantly higher 
than among the non-depressed. The SMRs among depressed men and women did not 
differ from those in the general Swedish population. 
 
Conclusions  
The prevalence and severity of depression was comparable to that in other primary care 
settings. Depressed women had often mentioned mental symptoms. Questions about 
family and working situation, feeling very stressed and feelings about one’s physical 
health could be used as risk indicators for depression in clinical practice for both men 
and women. Moreover, the long-term follow-up underlines the importance of finding 
patients with depression and thoroughly examine them also regarding their somatic 
health. 
 
Keywords: Depression, primary care, gender, screening, psychosocial 
stress, mortality. 
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INTRODUCTION 
Why study depression? 
Depression in the medical context is a mental disorder with a depressed state of mind 
that affects the individual’s quality of life and social functioning (1). It entails 
considerable costs to society due to reduced working capacity and high health care 
costs (2). 
The prevalence of depression in primary care settings has been found to be high and 
comparable to the prevalence of diabetes (3-6). 
The diagnosis of depression has been reported to be overlooked in primary care in 
about half of the patients (4, 7-9) and screening procedures have been discussed as a 
method to improve the detection of depression in primary care (10, 11).  
New drugs for the pharmacological treatment of depression, the serotonin reuptake 
inhibitors (SSRIs), had been available for prescription since the early 1990s
 
and were 
reported to have fewer and milder side effects than earlier pharmacological therapies. 
Despite the fact that prescriptions for SSRIs doubled in Sweden between 1991 and 
1996 (12), studies have shown that many depressed patients in primary care were not 
treated according to the guidelines at that time (13, 14).  
It was considered an important issue for clinical practice and research to improve the 
methods for detecting depression in primary care. Together with my colleague I started 
these studies in 1997 at a health centre in central Stockholm, Sweden. We wanted to 
investigate the prevalence and severity of undiagnosed cases of depression in this 
primary care setting, also with a focus on men, as depression among men might be 
more frequently overlooked than among women (15).  
Personal reflections 
I had been working as a primary care physician for about ten years when the reorganis-
ation called ‘Kvartersakuten’ (small primary care centres in a neighbourhood), was 
implemented in 1991, in the centre of Stockholm. The number of primary care 
physicians was doubled and each primary care physician, in cooperation with a district 
nurse, became responsible for about 2000–2500 inhabitants living in specified quarters, 
so as to establish continuity of care. In order to increase the patients’ access to their 
primary care physicians, ‘drop-in hours’ were introduced. This organisational model 
had proved to be cost-effective with increased primary care physician visits and 
reduced visits to the hospitals’ emergency departments and to private specialists (16, 
17). The waiting room for the ‘drop-in hour’ was full of patients every morning and our 
experience was that many women were frequent attendees.  
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BACKGROUND 
Organisation of primary care  
General tasks  
A law concerning primary care physicians was implemented in 1994 and defined the 
responsibility for primary care in Sweden so as to comprise all primary health care 
needs for the inhabitants (18). All inhabitants should be assigned, actively or passively, 
to specialists in family practice and each physician should have between 1000 and 3000 
listed patients and cooperate with district nurses. 
Psychosocial care  
At the time when we started the studies in 1997, two social counsellors were employed 
and worked in one of the primary care centres (PCCs). They were skilled in social 
counselling and had psychotherapeutic training to varying degrees and handled many 
problems, e.g. in family relations and crisis reactions, and primary care physicians 
referred patients to them. The charge for these consultations was low. At this time 
therapy by a psychologist was too expensive for the majority of the patients, as this care 
was not reimbursed by the county council. When the new systems for financial com-
pensation for PCCs were implemented the social counsellor positions at the centres 
were closed. This was regrettable, since counselling by social workers in primary care 
in Scotland had been found to be cost-effective and, among women with mild 
depressions, more effective than pharmacological treatment and treatment by 
psychotherapists (19).  
Today a primary care physician is usually responsible for about 1800–2600 listed 
patients and cooperates in PCCs with other physicians, district nurses and other 
personnel categories. About half of the primary care physicians in Stockholm work in 
privately operated PCCs. The financial compensation to the PCCs is today based on the 
number of listed patients and the number of consultations. 
The length of a scheduled consultation is often about 20 minutes, which is longer 
than in many other European countries, but in Sweden patients have fewer consult-
ations with their primary care physicians. The unscheduled consultations at the drop-in 
hours are shorter, about 10 minutes.  
Depression – Definitions  
What is depression? 
In everyday conversation the term ‘depressed’ might be used to mean temporary 
feelings of low mood, connected with disappointments and shortcomings, but in the 
medical context, depression is a mental disorder with defined diagnostic criteria.  
Definitions of depression in three diagnostic systems 
Three diagnostic systems for diagnosing mental disorders were in use at the time of our 
studies and are still in use today: 
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1. The International Statistical Classification of Diseases and Health Related Problems, 
(ICD-10) was developed by the World Health Organisation (WHO) (20). It is used 
worldwide and classifies all diseases and other health problems and has specific 
diagnostic codes for diseases. A ‘depressive episode’ is defined as a combination of 
symptoms, which are grouped in A, B and C criteria. The core symptoms are low 
mood, low energy and low activity, and at least 1–2 of these must be combined with a 
specified number of other symptoms from the C category to make the diagnosis, and 
the B category defines the exclusion criteria. Separate codes for a mild (F32.0), 
moderate (F32.1) or severe (F32.2) depressive episode are available and based on the 
number of symptoms and the level of impairment. In mild depression, normal daily 
activities can be performed; in moderate depression, normal daily activities are difficult 
to get through. In severe depression, the patient is gravely impaired and has suicidal 
thoughts. Severe depression with psychotic symptoms has a separate code (F32.3). 
Recurrent depressive disorder (F33.0) is the diagnosis used when depressive episodes 
occur repeatedly. Seasonal depressive disorder is a label used for recurrent depressive 
disorders during a specific season, often in the autumn or spring.  
Depressive episodes alternating with elated mood are termed bipolar affective 
disorder (F31), with many further specifications. 
 
2. The classification register for use in Swedish primary care, ‘Klassifikation av 
sjukdomar och hälsoproblem 1997 – Primärvård, (KSH97 – P)’ is a shortened version 
of ICD-10 (21). Diagnoses available for depressed mood are: ‘Depressive episode’ 
(F32), ‘Recurrent depressive disorder’ (F33), ‘Neurotic depression’ (in Swedish, 
‘Förstämningssyndrom’) (F39-P) and ‘Bipolar affective disorder’ (F31). Several 
versions of the KSH97 – P were and are in use in primary care, but none of these have 
separate codes for mild, moderate or severe depression. 
Other possible diagnoses used to classify depressive symptoms are ‘Reaction to 
stress, Crisis reaction’ (F43.9P) and the symptom describing diagnosis ‘Symptoms of 
burnout’ (Z73).  
 
3. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-
IV) was issued by the American Psychiatric Association (22). It defines the diagnostic 
criteria for mental disorders including major depressive disorder (MDD). Five 
symptoms, of which one of two mandatory symptoms, depressed mood or loss of 
interest or pleasure, have to be combined with at least four additional symptoms 
(Appendix). 
In this thesis the diagnosis of depression was based on the criteria for MDD in 
DSM-IV. 
Other diagnoses with low mood relevant in primary care 
Minor Depression 
According to DSM-IV, two up to four symptoms must be present for the diagnosis 
Minor Depression compared to five symptoms in MDD. In research, the term ‘Minor 
Depression’ has had several definitions (23). Minor depression may occur indepen-
dently of MDD or as a stage of MDD and is also associated with functional impairment 
(24, 25). 
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Burnout  
Mental diagnoses as a reason for long-term sick leave had increased greatly during the 
last years of the 1990s (26). Work-related stress was also often noted in the sick-listing 
certifications (27). Long-lasting exposures to stress could produce symptoms of 
burnout with the core symptoms of lack of energy and rapidly increasing symptoms of 
memory and concentration problems (28). In 2003 the National Board of Health and 
Welfare in Sweden published diagnostic criteria for the diagnosis ‘Depression with 
burnout syndrome’ or, alternatively, ‘Burnout depression’ (27). The diagnostic code for 
‘Depressive Episode’ (F32) should be used if criteria for MDD are fulfilled. In less 
severe cases the diagnoses ‘Burnout syndrome’ or ‘Maladaptive reaction to stress’ can 
be used (F43.8A).  
Severity of depression 
In clinical practice, it is important to follow the effects of treatment with assessments of 
the severity and the risk of suicide. The ICD-10 and DSM-IV include definitions of 
mild, moderate and severe depression. More precise assessments were developed to 
evaluate the effects of pharmacological treatment of depression in clinical practice and 
research, i.e. the Hamilton Depression Rating Scale (HDRS) (29) and the Montgomery-
Åsberg Depression Rating Scale (MADRS) (30). The MADRS has been shown to be 
more sensitive to change when depressed patients were treated with antidepressants.  
Montgomery-Åsberg Depression Rating scale  
The ten items in the MADRS (total score 0–60, each item six steps, 0–6) cover the 
diagnostic criteria of depression in DSM-IV, except for motor retardation. The severity 
can be classified on the basis of the summed score as: no clinical depression (<7), mild 
depression (7–19), moderate depression (20–34) or severe depression (35–60) (31).  
Suicide and major depressive disorder  
In Sweden the number of suicides was 1783 in 1995. During the last few decades the 
number of suicides in Sweden and in Finland has decreased, which might be an effect 
of the increased prescription of SSRIs and other anti-depressive pharmacological 
treatments (32-34). However, the frequency of suicides had decreased before the 
increase in the new anti-depressive treatments (35) and many countries in Europe have 
not noted any decrease in suicide rates despite increasing prescriptions of SSRIs (36). 
The majority of suicides are related to MDD (37, 38). Suicidal ideation has also 
been found to be common among depressed patients in primary care in Finland (39). In 
Swedish psychiatric care the risk of suicide was found to be very high among depressed 
patients (40). The risk of suicide has been shown to increase with the severity of 
depression (41).  
In a Danish study it was shown that the majority of patients who had committed 
suicide had been in contact with health care providers some weeks before the suicide 
(42).  
 15 
Depressed patients in psychiatric and in primary care 
Psychiatric care  
The regional treatment guidelines advised that the following patients with depression 
should be referred to psychiatric care: those with severe depression and suicidal 
ideation, those with psychotic symptoms, those with bipolar disorders and those with 
depression after childbirth (43). 
Primary care 
The majority of the depressed patients were and still are treated by their primary care 
physicians. In primary care, depression is one of the most common diagnoses (44). The 
prevalence of persons on SSRI treatment has steadily increased in Sweden, and is now 
about 7% and, in elderly patients, about 20% (45). Primary care physicians see un-
selected patients, often with several diseases. Thus, the clinical pictures of depression in 
psychiatric care and primary care are different.  
Prevalence, duration and recurrence  
The prevalence of depression in primary care has been estimated in European studies to 
range between 10% and 24%, depending on the study population and methods used 
(46-48). The detection rates have been found to be higher in cases of severe depression 
(49, 50), as well as in continuous care (51, 52). 
The prevalence among women has been reported cross-culturally to be twice that of 
men (15, 53-55). The reasons for this higher prevalence have not been fully understood 
(56, 57), but the excess among women was reduced by about 50% when adjusted for 
socio-financial factors (54).  
Notably, population studies have shown that not all depressed patients seek help for 
their problems (58). 
Duration and recurrence 
Population studies from the Netherlands on the duration of MDD have reported that 
half of the patients had recovered within three months, but 20% still had depression 
after two years (59). The recurrence rates of MDD in primary care have been reported 
to range between 30% and 40% (60). Because of the duration and recurrence rate, the 
burden of MDD is evident (61). 
Clinical picture in primary care 
Depression is a syndrome diagnosis with at least 14 combinations of the symptoms 
from the MDD criteria. According to several studies, the majority of depressed patients 
in primary care consultations had presented somatic symptoms, such as pain in the 
head, back, chest or stomach, musculoskeletal pain, loss of appetite, constipation and 
fatigue and, in about two thirds of cases, combined with other psychiatric diagnoses 
(62, 63). 
Patients with depression have rated their quality of life as low as that of patients who 
have had a severe stroke (64). Depressed patients have been shown to be frequent 
attendees at all health care levels because of feelings of illness and worries (65-69).  
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Quality of life and social functioning 
Regardless of its severity (1, 5), depression has negative effects on the individual’s 
quality of life (64), social functioning and working life (24, 70, 71). Particularly, early 
onset of depression in women has been found to highly affect their educational 
attainment and thus involves a large loss of human capital (72).  
Comorbidity  
Depressed patients in primary care often have comorbid somatic diseases. Diabetes is a 
prevalent disease in primary care, and a meta-analysis found that patients with diabetes 
had a doubled risk of depression compared with patients without diabetes (73). 
Depression was found to be associated with an increased risk of heart disease among 
men and women and increased mortality from heart disease among men (74).  
Comorbidity with other psychiatric disorders 
A WHO study on primary care patients from 15 countries showed that about two thirds 
of depressed patients had additional mental disorders such as anxiety disorders, alcohol 
dependency or personality disorders (63).  
Alcohol: Population studies in the USA had shown that persons affected by alcohol 
abuse or dependence had more than a twofold increased risk of anxiety and depressive 
disorders (75). Other later studies have reported a dose-response relationship between 
alcohol and depression (76, 77). A combination of harmful or hazardous alcohol use 
combined with depression has been shown to increase the risk of suicide, especially 
among men (78). Patients with depression, anxiety and high alcohol consumption have 
also been shown to be frequent primary health care users (69). 
In Sweden the recommendation for safe limits of alcohol use was for men not to 
exceed 14 standard glasses (stg) (1 stg = 12 g pure alcohol) per week and for women 
not to exceed 9 stg per week.  
Anxiolytic treatment: Depressed patients have increased levels of anxiety. Earlier, in 
the 1970s and 1980s, anxiolytic treatment with benzodiazepines was in widespread use 
and some patients developed a dependency (79). Today the rate of benzodiazepine 
descriptions is lower, but in a survey in Belgium and Luxemburg half of the patients 
with generalised anxiety disorder (GAD) and MDD were treated with benzodiazepines 
(80). 
Illegal use of drugs: Use of cannabis has been shown to increase the risk of depres-
sive symptoms and suicidal ideations (81) and also predicted later depression in teenage 
girls (82). 
Mortality 
Depressed patients treated as in-patients in psychiatric care have been shown to have 
increased standardised mortality rates compared to the general population (40). There 
were at the time no studies on mortality in primary care, but one Dutch study reported 
no higher mortality rate among depressed patients than among non-depressed patients 
(83). 
Significance of depression in society 
Societal costs for depression doubled between 1997 and 2005 due to losses of working 
capacity and sick-listing (2). The costs for sick leave increased rapidly from 1997 and 
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peaked in 2003 mainly because of increased numbers of cases with psychiatric 
diagnoses (84), especially among women (85) with burnout depression/burnout 
syndrome who were employed in the public services (86). The number of sickness 
benefit days, the number of days/ individual (16–64 years)/year who received sickness 
insurance. It was at an all-time high level in 2002 reaching among women 52 days, and 
among men 35 days according to the Swedish National Audit Office.  
Risk factors for depression 
The prevalence of depression in women peaks at the age of 25–45 years pointing out a 
vulnerable period in women’s lives (87) and single mothers as an especially vulnerable 
group (88). 
Depression and socioeconomic status (SES) are associated and low SES signified a 
higher risk of being depressed (89). Other risk factors have been recognised, such as 
negative life events, poor physical health, poor interpersonal relationships, poor 
socioeconomic conditions and alcohol problems (90). 
The influence of heredity has been reported to be important only in severe 
depression (91). 
Migration has an enormous effect on nearly all aspects of the individuals’ lives, and 
immigrant status often involves an increased risk of mental disorders and suicides (92-
94). 
Good prognostic factors for the outcome of depression were found to be initially 
mild depression, high educational level, being employed and stable life situation (95). 
Gender differences  
Female gender can be viewed as a risk factor for depression because of the higher 
prevalence (55). 
Threatening life events involve a risk of developing depression, and women were 
found vulnerable to events involving children, housing and reproductive problems and 
men to financial problems (96). 
Gender-related risk factors for depression have been investigated in the population 
study conducted in Lundby, Sweden where differences were identified in personality 
traits such as being nervous/tense, which was a risk factor in both men and women 
(97). 
One gender difference regarding lifestyle was noticed in US primary care regarding 
hazardous drinking, which was present among 19% of men and 8% of women with 
depressive symptoms (98). In recent years Swedish women have developed more 
harmful alcohol habits, especially young women (99).  
Men have a higher rate of suicide than women (100, 101). Notably, the number of 
suicides decreased solely among women as a result of an educational programme in 
primary care regarding treatment of depression (102). It was therefore suggested that 
depressed men might communicate other symptoms when depressed and thus might not 
have been recognised by health care personnel (37). A male depressive syndrome has 
been postulated by psychiatrists to include symptoms such as attacks of anger, use of 
alcohol in order to calm down, extensive working and jogging, heredity of depression 
or suicidal behaviour or alcohol abuse, or gambling (103-105). 
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Once the male depression syndrome had been discussed, the Gotland Male Depres-
sion Rating Scale (GS) was developed to be especially appropriate for screening men 
(106). 
Guidelines for treatment in primary care  
Guidelines for managing depression were found in textbooks in psychiatry and family 
medicine at the time the study was being planned. They were also found in 
‘Läkemedelsboken’, a book with updated overviews of common diagnoses and their 
treatments distributed to all physicians in Sweden (107). The importance of establishing 
a good therapeutic alliance with depressed patients was pointed out, as well as using 
patient-centred consultations, discussions of pharmacological treatment and considering 
a psychotherapist contact. 
Also, physicians from local Drug Therapeutic Committees visited the PCCs in 
Sweden regularly and informed about appropriate diagnoses and therapies. Regional 
Guidelines for Depressive Disorders are presented electronically in the County of 
Stockholm at www.viss.nu since 2007. 
Detecting depression in primary care  
Many studies in the 1990s reported missed diagnoses of depression in primary care, but 
the severity of the missed cases was not discussed (46, 108-111). Later studies have 
shown higher detection rates for severe depressions (50) and in continuous care (112).  
An English study found that primary care physicians had set a diagnosis of 
depression in the medical records only when it was severe (113). Higher rates of 
diagnosed depression have been demonstrated among women and persons with a 
higher level of education (7). Physicians’ attitudes to setting a diagnosis in the medical 
record have been studied in the USA. It was found that in about one third of the patients 
with MDD other diagnoses were set in the medical record, and one reason for the 
physicians’ hesitation was that the diagnosis might involve harm to the patients, i.e. 
loss of some insurance benefits (114). 
Comorbidity with somatic diseases has been shown to be a barrier to detect 
depression, as management of the somatic topics tends to take up the whole of the 
consultation (115). A literature review has reported that a longer consultation time was 
associated with a more accurate diagnosis of psychological problems (116).  
Screening instruments  
Many screening instruments with high validity are available for screening for 
depression (117). However, none of the instruments is diagnostic.  
The four most frequently used self-rated screening instruments in primary care are 
the Hospital Anxiety and Depression Scale (HADS) (118), the Prime-MD (119), the 
Patient Health Questionnaire (PHQ 9) (120) and the Montgomery-Åsberg Depression 
Rating Scale, self-rated version (MADRS-S) (121, 122). The overall sensitivity was 
reported to be 84% (95% CI: 79% to 89%) and the specificity to be 72% (95% CI: 67% 
to 77%) (123).  
The Swedish Council on Health Technology Assessment (SBU) has recently stated 
that the sensitivity of a screening instrument for depression should reach 80% to be 
acceptable, and SBU found that the Beck Depression Inventory, second version (BDI–
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II), had high enough sensitivity, in contrast to PHQ-9 and HADS, which did not reach 
the required level of sensitivity to be evaluated as useful for screening of depression 
(124). 
Another method, where the doctor asks only two questions face-to-face, showed a 
sensitivity of 97% (95% CI: 83% to 99%) and a specificity of 67% (95% CI: 62% to 
72%) (125). Also, one single question: ‘Have you felt depressed or sad much of the 
time the past year?’ was found to have a sensitivity similar to longer questionnaires 
(126). 
Beck’s Depression Inventory 
Beck’s Depression Inventory (BDI) was constructed by Aaron T. Beck and based on 
clinical observations of depressed patients (127). It was revised in 1978. Beck stressed 
the cognitive genesis of depression and noted that negative thoughts were central in 
depressed patients. Of the 21 items (score steps 0–3, total score 0–63), 13 cover 
emotions, four contain behavioural dimensions and four cover somatic symptoms. The 
recommended cut-off score for screening for depression among medical patients was 
BDI ≥ 10 (128). The BDI score provides guiding information about the severity of 
depression, where less than 10 indicates no or minimal depression, 10–18 mild to 
moderate depression, 19–29 moderate to severe depression and scores of more than 30 
severe depression (129). 
The diagnostic validity has been studied in different settings, including primary care 
(129-131). In population studies using the cut-off score of ≥ 10, the sensitivity was 
84.6% and the specificity 86.4% (128). In a community sample using the cut-off score 
of ≥ 13 with an interview by a psychiatrist as the gold standard, the sensitivity was 
100% and the specificity was 99%, the positive predictive value was 72% and the 
negative predictive value was 100% (132). Recently, the revised BDI, BDI II, was 
regarded as one of the best-validated instruments for screening adult patients for 
depression with a sufficiently documented sensitivity, with a cut-off score of 14 (133). 
The Gotland Male Depression Scale  
The Gotland Male Depression Scale (GS) was presented in 1997 at the National 
Convention of Physicians (Läkarstämman) in Sweden. It is a self-rated screening 
questionnaire with items covering specifically the symptoms described in male 
depression syndrome in addition to items regarding depressed mood (106). At an 
alcohol outpatient clinic the correlation between GS and Major Depression Inventory 
was 0.77 (134). The correlation between GS and WHO-5 among young men enrolling 
for military service was reported to be –0.56 (135, 136). However, the GS has not 
been validated among patients in primary care. 
Opportunistic and targeted screening 
Opportunistic screening 
Opportunistic screening signifies that unselected patients are screened for a disease 
whenever they contact health care. Opportunistic screening for depression in primary 
care, without any organisational enhancements, had no effects on the diagnostic rates or 
outcome of depression and therefore has not been recommended in the Cochrane 
Report (137). 
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Targeted screening  
Targeted screening signifies that screening is restricted to individuals who have a 
known increased risk of the disease or symptoms of the disease. Targeted screening as 
a method for finding cases of depression has been mentioned in the Cochrane Report 
(137) and has been studied in Denmark (138), the USA (139) and the Netherlands 
(140). 
Two-step screening method  
A two-step screening method was mentioned in the Cochrane Report as a method that 
increases the detection rate of depression (137). This method means that patients are 
first screened with a screening instrument and, in the second step, only those with 
screening scores above the cut-off limit are interviewed according to the diagnostic 
criteria. 
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KNOWLEDGE GAPS 
At the start of the project, we identified the following main knowledge gaps:  
 
 Few studies had reported on the prevalence and severity of depression among 
unselected patients attending drop-in clinics in settings with good socio-
demographic conditions.  
 
 Few studies had reported on depression in men and women attending primary 
care centres with regard to clinical cues for detection and the usefulness of 
different screening scales. 
 
 Gender differences regarding depression and the association with psychosocial 
stressors and lifestyle factors, including alcohol consumption, were sparsely 
reported.  
 
 The long-term mortality was not known regarding patients in primary care who 
were once diagnosed as having had depression.  
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AIMS 
OVERALL AIMS  
To improve the methods for detecting patients with depression in primary care, with 
special reference to gender differences.  
To identify clinical and social characteristics which could be used as clinical cues to 
identify patients in need of further diagnostic assessment regarding depression. 
To explore the mortality rate in depressed patients diagnosed in primary care in a 
12-year follow-up perspective. 
SPECIFIC AIMS 
Study I 
1. To estimate the prevalence and severity of depression among unselected women 
visiting the participating physicians’ drop-in clinics.  
 
2. To explore possible differences in socio-demographic and clinical characteristics 
between depressed and non-depressed women. 
 
3. To evaluate the usefulness of the two-step screening method among women in 
clinical practice.  
Study II 
1. To estimate the prevalence and severity of depression among men visiting the 
participating physicians’ drop-in clinics.  
 
2. To compare the usefulness of the Gotland Male Depression Scale with that of the 
Beck Depression Inventory for detecting depression among men.  
 
3. To compare the results obtained from opportunistic screening with the results from 
targeted screening and to evaluate the two-step screening method among men.  
Study III 
1. To explore possible associations between depression, socio-demographic conditions, 
psychosocial stressors and lifestyles in depressed and non-depressed men and women. 
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Study IV  
1. To explore the all-cause mortality rates during a 12-year follow-up period among 
depressed and non-depressed men and women and possible associations with socio-
demographic, psychosocial and lifestyle factors.  
 
2. To explore the all-cause mortality in this cohort in comparison with all-cause 
mortality in the general Swedish population.  
 
3. To explore the proportion of unnatural causes of death among the depressed patients. 
 
 
HYPOTHESES 
Study I 
We expected to identify a number of women with undiagnosed depression among the 
women visiting drop-in clinics and to find some differences in socio-demographic and 
clinical characteristics between depressed and non-depressed women.  
Study II 
We expected to find more depressed men by using the screening scales GS and BDI 
jointly than by using the BDI alone, and that opportunistic screening would be less 
effective than targeted screening for finding men with depression.  
Study III 
We expected to find differences in psychosocial stressors and lifestyle factors between 
men and women.  
Study IV 
We expected that the depressed patients would have higher mortality rates during the 
follow-up period compared to the non-depressed patients, also when adjustment was 
made for age and other risk factors, and in comparison to the general population in 
Sweden. Furthermore, we expected that unnatural causes of death might be prevalent 
among the depressed patients.  
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PATIENTS AND METHODS  
Design 
Studies I, II and III had cross-sectional designs. 
Study IV had a prospective design. 
Setting 
The studies were conducted at a Primary Care Centre (PCC) in Kungsholmen, in 
central Stockholm, Sweden. This PCC provided health services for approximately 
10,000 persons living in the area, and listed with a ‘personal physician’ among the five 
specialists in family medicine at the centre. All physicians at the PCC had been 
working at the centre for many years.  
Each physician had approximately 16–20 consultations daily and two thirds of the 
patients were women. Half of the consultations were unscheduled 10-minute visits 
during the drop-in hour, which was usually extended to two hours. All physicians at the 
PCC had their drop-in hours simultaneously. 
Power estimation 
We aimed to sample a minimum of 30 depressed men and 30 depressed women. The 
estimated prevalence of depression was 10% in men and 20% in women. Furthermore, 
we estimated a dropout rate of 10%. We applied for and received approval from the 
Ethics Committee to screen 500 patients altogether. 
Sampling procedure 
The sampling of men and women started in October 1997. The target group was men 
and women aged 18–75 years, who were patients at the drop-in clinic of the two 
participating female physicians. Sampling of women continued to the end of December 
1998 and sampling of men continued until January 2001.  
Both opportunistic and targeted screening was used. 
Opportunistic screening 
Study population  
In the opportunistic screening, unselected patients aged 18–75 years visiting the two 
physicians’ drop-in clinics were invited at random days by a study nurse to participate 
in the study. Upon consent, they were asked to fill in the Beck Depression Inventory 
(BDI) and a social condition questionnaire (SC) before the consultation with the 
physician and to return them to the nurse. 
Patients who could not answer the questionnaires in the study unaided, e.g. due to 
dementia or language barrier, were excluded.  
From the start of 1998 the Gotland Male Depression Scale (GS) was distributed to 
both men and women together with the BDI and SC.  
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The flowchart (Figure 1.) shows the sampling results from the opportunistic 
screenings of the women and the men. Out of the invited 155 women, 92% agreed to 
participate. Finally, 135 (87%) completed the BDI correctly, thus female participants 
numbered 135.  
Out of the 254 invited men, 88% agreed to participate and completed the BDI 
correctly, thus male participants numbered 223. 
 
 
 
Declined/incomplete questionnaires
Women n = 20 (13%) 
Men       n = 31 (12%)
Total      N = 51  
BDI < 10 (No depression)
Women n = 76   (56%)*
Men       n = 177 (79%)
Clinical interview/DSM-IV&MADRS
Women n = 50 (85%)
Men        n = 34 (74%)
No depression/No 
psychiatric diagnosis
Women n = 4
Men      n = 6
Psychiatric
patients
Women n = 3
Men      n = 0 
BDI > = 10 (Possible depression)
Women n = 59 (44%)
Men        n = 46 (21%) 
Study population/participants
Women n = 135 (87%)
Men       n = 223 (88%)
Total      N = 325  
Invited patients  in opportunistic screening
Women n = 155
Men       n = 254 
Total      N = 409
Dropouts/abstained
Women n = 9  (15%)
Men       n = 12 (26%)
Depression
Women n = 35  35/135 (26%)
Men      n = 23  23/223 (10%)
Total    N = 55  (17%)
Crisis
reactions
Women n = 8
Men     n = 5
 
 
Figure 1. Flowchart of the opportunistic screening of men and women visiting the PCC 
drop-in clinic screened with BDI. MDD diagnosed according to DSM-IV criteria by the 
physicians and severity of MDD assessed with MADRS.  
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Targeted Screening  
Study population  
Use of targeted screening signifies that only patients with known risk factors or 
symptoms of disease or disorder are screened. The participating physicians used 
targeted screening on the days when the study nurse was not working. 
Patients (aged 18–75 years) who seemed to have low mood, wept or presented such 
symptoms as tiredness, anxiety, stress, sleepiness or concentration problems were 
invited to participate in this study. They received the questionnaires after the visit and 
returned them by post.  
The flowcharts in Fig. 2 and Fig. 3 show the study populations from the targeted 
screenings of men and women.  
 
 
 
Invited men to targeted screening BDI 
Men n = 45
(No dropouts)
BDI < 10
n = 10 (24%)
No depression
n = 4  
(including crisis reactions n = 2) 
BDI  ≥ 10
n = 26 (58%)
Clinical interview/DSM IV&MADRS
n = 26 (100%)
n = 3  BDI<10 
Depression
n = 22    BDI ≥ 10  (22/45 =49%)
n =3     BDI<10       
Depressed men total n=25  (25/45= 56%)  
BDI < 10
n = 19 (42%)
Invited to interview n= 3 
 
 
Figure 2. Flowchart of the targeted screening with BDI of men who visited the PCC 
drop-in clinic. MDD diagnosed according to DSM-IV criteria by the physicians and 
severity assessed with MADRS.  
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Invited women targeted screening/BDI/SC 
Women n = 59
(No dropouts)
BDI < 10
n = 20 (34 %)
Invited to interview n = 5 
No depression
n = 6 (14 %) 
(Incl crisis reactions n=3) 
BDI  ≥  10
n = 39 (66%)
Clinical interview/DSM IV&MADRS
n = 39 (BDI ≥10)
n =5    (BDI<10) 
Depression
n = 39 (BDI ≥10) (66%)
n = 5  (BDI<10)    (8%)
Depressed women total N = 41 (69%)
 
 
Figure 3. Flowchart of the targeted screening with BDI of women who visited the PCC 
drop-in clinic. MDD diagnosed according to DSM-IV criteria and severity assessed 
with MADRS.  
 
 
Thus, in summary, there were 104 participants from the targeted screening, 45 men and 
59 women. Three men and 5 women with BDI < 10 were interviewed because of 
clinical suspicion of depression and are added in the squares ‘clinical interview’.  
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Questionnaires, measurements and data sources 
Beck’s Depression Inventory (BDI)  
BDI was regarded as one of the best validated instruments for screening adult patients 
for depression, with a high enough documented sensitivity and with a cut-off score of 
14 (133). The BDI revised version with 21 items, was used in its self-rating form, 
where each item is rated 0, 1, 2 or 3 and the total score ranges from 0 to 63 The 
recommended cut-off score of ≥ 10 for medical patients was used (128). It takes 5–10 
minutes to complete the BDI.  
The Gotland Male Depression Scale  
The GS contains 13 items with scale steps of 0, 1, 2, 3 and a total score range of 0–39. 
Besides questions about depressed mood, the GS also includes items supposed to 
predominate in depressed men, i.e. anger attacks, overactive working or sport activities, 
heredity for suicidal behaviour and harmful alcohol consumption.  
In the original questionnaire, two questions, 9 and 13, contain more than one 
statement. Therefore, these questions were divided into 9a and 9b and 13a, 13b and 13c 
and our questionnaire contains 16 questions. We adjusted the answers in questions 9 
and 13 so that the total score did not increase. For example, when a person had scored 2 
on both 9a and 9b, we adjusted this to a sum of 3 (not 4). In this way, we were able to 
use the cut-off scores suggested by the constructor of the GS. 
The recommendation from the authors to interpret the total score on the GS was: 
 
0–13 No indications of depression  
14–26 Possible depression, consideration of pharmacological treatment 
27–39 Indicates presence of depression, pharmacological treatment indicated  
Social Characteristics Questionnaire 
The Social Characteristics (SC) Questionnaire was constructed by the researchers to 
obtain information on:  
1. Socio-demographic data: Age, marital status, number of children, education, 
employment, sick leave and health care contacts during the year before inclusion in the 
study.  
2. Psychosocial stressors and life circumstances: Financial situation, satisfaction 
with one’s work, family or housing situation, perceived level of stress and perceived 
physical health. Five fixed alternatives were given. These were dichotomised in order 
to identify a high level of discomfort. (Example: ‘How do you rate your physical 
health?’ the answers ‘poor’ and ‘quite poor’ were dichotomised as poor and ‘excellent’ 
and ‘very good’ and ‘good’ as good.  
3. Lifestyle questions about smoking and alcohol consumption were included. We 
asked about daily smoking (Yes or No). 
The question about alcohol was formulated as: ‘How much alcohol do you consume 
during an average week?’ A picture was attached showing several common drinks 
representing one standard glass (stg) of alcohol (e.g. one glass, 15 cl, of wine equals 
one stg alcohol) (141). The patients noted the sum of each sort of consumed stg.  
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A consumption of ≥ 15 stg by men and ≥ 10 stg by women was dichotomised as 
above the safe limit, and < 15 stg by men and < 10 stg by women as a safe limit. 
4. In addition, the SC questionnaire included questions about weight and height, and 
problems with pain and pain intensity recorded on a visual analogue scale. Two 
questions with open text answers were included: ‘Do you have any somatic diseases or 
handicaps?’ and ‘Has anything serious happened to somebody in your family or among 
your close friends? ’ 
Diagnostic and Statistical Manual of Mental Disorders, 4th Edition 
Depression was diagnosed in a face-to-face interview with the physician according to 
the criteria for major depressive disorder (MDD) in the Diagnostic and Statistical 
Manual of Mental Disorders, 4th Edition (DSM-IV) (142).  
Montgomery-Åsberg Depression Rating Scale  
The severity of depression was measured using the Montgomery-Åsberg Depression 
Rating Scale (MADRS) containing 10 items with scale steps 0–6 and a total range of 0–
60 (30). The first two questions in the MADRS are observer-related. The other items 
are also rated by the observer in discussion with the patient. The following 
recommended cut-off scores for assessing severity were used, with the score range of 
0–6 interpreted as absence of depressive symptoms and score ranges of 7–19 as mild 
depression, 20–34 as moderate depression and 35–60 as severe depression (31).  
Chart notations 
The chart notations were examined by two of the authors for symptoms mentioned at 
the index visit. Symptoms of anxiety, distress and being worn out, and feelings of low 
mood, sleeping problems or fatigue were categorised as mental symptoms, other 
symptoms as somatic.  
The National Cause of Death Register 
From the National Cause of Death Register, a database comprising all death certificates 
in Sweden, managed by the National Board of Health and Welfare was used to obtain 
the causes of deaths regarding the depressed patients. Commitment from the Ethical 
Board was obtained. The death certificates are classified as secret.  
The Swedish National Population Register 
The Swedish National Population Register is an open database comprising all persons 
registered as living in Sweden (143). All deaths are noted in there along with the date of 
death. Commitment from the Ethical Board was obtained to require the dates of deaths 
for the patients who did not have any psychiatric disease. 
Statistics Sweden  
Statistics Sweden is an annual publication that includes information on life expectancy 
in Sweden in the Life Tables regarding all ages (144).  
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Procedures after the screening 
Evaluation of the questionnaires  
The questionnaires were evaluated by the physicians after the index visit.  
Three categories of participants were invited by letter to a repeat visit by their 
physician for a clinical interview concerning depression within two weeks:  
 
1. Participants who scored BDI ≥ 10. 
2. Men who scored GS ≥ 13.  
3. Participants reporting a consumption of alcohol above the safe limits of standard 
glasses of alcohol/week (women, ≥ 10 standard glasses; men ≥ 15 standard glasses). 
 
The invitation to the repeat visit was sent three times if needed. 
Diagnosing depression and assessment of severity 
At the repeat visit the DSM criteria were applied to diagnose a possible depression, and 
when found, MADRS was applied to assess its severity. Diagnosis and treatment were 
discussed, as were the patient’s answers to the questionnaires as well as other health 
problems. Moreover, if alcohol consumption was above the safe limits, treatment was 
started according to guidelines.  
STUDY POPULATIONS  
Study I 
The study population consisted of women recruited by opportunistic screening when 
they visited the drop-in clinic who had completed the BDI (Fig. 1). The number of 
participants was 135 women with a mean age of 46.2 years (95% CI: 43.4–48.9).  
Study II  
The study population consisted of men recruited by opportunistic or targeted screening 
who had completed the BDI and the GS. The number of participants was 223 men, 190 
from opportunistic screening and 33 from targeted screening. Their mean age was 42.7 
years (95% CI: 40.8–44.7). 
Study III  
The study population consisted of both the men and the women from both the 
opportunistic and the targeted screenings with BDI. The total study group consisted of 
404 participants, i.e. the opportunistically screened 266 men and 135 women, and the 
targeted screened 45 men and 59 women. The participants were 48 depressed men 
(opportunistic screening n=23, targeted screening n=25) and 76 depressed women 
(opportunistic screening n=35, targeted screening n=41) and the reference groups of 
187 men and 93 women. The reference group was made up of both the patients with 
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BDI < 10 and those with BDI > 10 who had no psychiatric diagnosis. There were no 
statistically significant differences in age between the groups of depressed and non-
depressed men and women.  
Study IV 
The study population was the same as in Study III. 
DROPOUTS 
Women 
The women who had declined participation in the opportunistic screening (n=12; 8%) 
did not differ significantly in age from the participants. The women who failed (n=8; 
6%) to complete the forms correctly were significantly older than the participants, with 
a mean age of 63.1 years. 
The women who did not turn up for the clinical interview were significantly 
younger than those who were interviewed, with a mean age of 27.8 years. 
There were no dropouts in the targeted screening. 
Men  
The men who declined participation had a mean age of 54.8 years, not differing in age 
from those who participated. The men who did not come to the interview (n=12, 26%) 
had a mean age of 41.7 years, not differing from those who were interviewed. 
ETHICAL ISSUES  
Approval was obtained from the Ethics Committee of Huddinge Hospital on 1 
September 1997 to screen 500 patients (Dnr: 232/97). Permission to use the GS 
together with the BDI was given by the chairman of the Ethics Committee of Huddinge 
Hospital on 27 July 1998. Permission to conduct study IV was given by the Ethical 
Review Board in Stockholm (Dnr: 2011/566-31/1). The ethical principles of the 
Helsinki Declaration were adhered to. All participants were given oral and written 
information about the study underlining that they could withdraw at any moment from 
the study without any consequences concerning care, and were informed that the data 
would be handed confidentially and that individual data could not be identified.  
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METHODS  
Study I 
Women visiting the two participating physicians’ drop-in clinics were screened using 
an opportunistic screening with the BDI with a cut-off score of BDI ≥ 10 and answered 
the SC.  
The women with BDI ≥ 10 were invited by their physicians to a repeat visit and 
interviewed regarding MDD according to DSM-IV criteria. If MDD was diagnosed, its 
severity was assessed using the MADRS. The treatment was planned in cooperation 
with the patient according to best practice principles. Physical examinations and 
necessary blood tests were performed. Care for other medical disorders was continued. 
Women who had reported their weekly alcohol consumption to be ≥ 10 stg were invited 
to counselling.  
The women with BDI < 10 constituted the control group.  
The prevalence of depression was calculated as well as the distribution of the 
severity of the depressions. The two-step screening method was evaluated based on 
participation rates and the prevalence of depression.  
The symptoms mentioned at the index visit were obtained from the medical charts 
and grouped as mental or somatic symptoms and the differences in their distribution 
were analysed. Possible differences in the distribution of socio-demographic character-
istics between the identified diagnostic groups and controls who had a BDI of <10 were 
analysed.  
In order not to miss depression among women with < 10 the physician also invited 
women to interview if they had mentioned symptoms suggestive of depression at the 
index visit. The outcome is reported separately and they were analysed in Study I as 
belonging to controls. 
Study II 
Men visiting the participating physicians’ drop in clinics were screened with 
opportunistic and targeted screening. Besides the BDI, GS was also used as a screening 
instrument. 
Socio-demographic data including alcohol consumption were received from the SC. 
The men with BDI ≥ 10 or GS ≥ 13 were invited by their physicians to a repeat visit 
for diagnostics concerning MDD according to DSM-IV. If MDD was diagnosed, the 
severity was assessed using the MADRS. 
In addition, the men who had reported alcohol consumption above the 
recommended safe limit of ≥ 15 stg were invited to a repeat visit. The treatment was 
planned in cooperation with the patient according to best practice principles. Physical 
examinations and necessary blood tests were performed. Care for other medical 
disorders was continued.  
The screening with the BDI was compared to the screening with GS regarding 
detection of MDD. 
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The prevalence of depression in opportunistic screening was calculated. The 
outcomes in the proportion of depressed men from the opportunistic and targeted 
screenings were compared.  
The two-step screening method was evaluated based on participation rates and the 
prevalence of depression.  
Study III 
The study population included all the men and the women screened by opportunistic or 
targeted screening. 
The depressed men were compared to the non-depressed men and the depressed 
women to the non-depressed women regarding the distribution of socio-demographic 
characteristics, psychosocial stressors and lifestyle choices. Patients defined as non-
depressed were those with a screening score BDI < 10 together with those who were 
identified in the interview as having no mental diagnoses. 
Logistic regression was used to calculate the association between depression and the 
possible risk factors in crude models and in main effect models separately for men and 
women, in order to identify the best risk factor models associated with depression. The 
risk factor models for men and women were compared with each other. 
Study IV 
The study population is the same as in study III. The dates of deaths and causes of 
deaths during the time period from inclusion of the participants in the study until 25 
September 2011 were obtained from the National Cause of Death Register. For the 
non-depressed patients the dates of deaths were obtained from the Swedish National 
Registration. Dates of deaths and causes of deaths were thereafter recorded using 
unidentified data. 
All-cause mortality data from the Life Tables from Statistics Sweden, based on the 
entire Swedish population were obtained for the same time period and the same age as 
the participants in the study and were used to calculate the standardised mortality rates 
(SMRs).  
The SMRs were calculated separately for men and for women in the study 
population and compared to the SMRs calculated for men and women the Swedish 
population in the in the same ages, during the same time period in (SMR=1). Socio-
demographic data and lifestyle variables were obtained from the SC. The mortality 
rates between depressed and non-depressed patients are compared. Cox regression, sex 
and age- adjusted was applied to estimate the Hazard ratios (HRs) for mortality in 
relation to the explanatory variables. Survival curves were created for depressed and 
non-depressed patients. Suicide, accident, intoxication and alcohol-related liver disease 
were classified as unnatural causes of death. 
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STATISTICS  
Statistical calculations were performed using STATA statistical software version 8 in 
Studies I–II and version 11 in Study IV (145).  
Study I  
Pearson’s chi-square test or Fisher’s exact test was used to analyse categorical data and 
significant differences in proportions. Two-sided significance tests were used and the 
level of the significance was set at 5%. Differences between groups regarding 
continuous variables were shown as means with 95% confidence intervals (95% CI). 
Ordinal data were described with medians and ranges. Pearson’s correlation coefficient 
was calculated to describe the correlation between age and the MADRS score. 
Study II 
Significant differences between proportions regarding categorical data and continuous 
data were analysed using the same statistical methods as in Study I. Ordinal data were 
described with medians and ranges. Spearman’s rank correlation coefficient was 
calculated to describe the relationship between GS and BDI. 
Study III 
Differences between proportions regarding categorical data and continuous data were 
analysed using the same statistical methods as in Studies I–II. Ordinal data were 
described with medians and ranges. Age-adjusted logistic regression for being 
depressed was used to estimate odds ratios (ORs) with 95% CIs for the explanatory 
variables. Multivariable logistic regression analyses were performed with manual 
stepwise inclusion of the actual variables. Model improvement was tested by applying 
the likelihood ratio test where p < 0.05 indicated model improvement. Finally, the 
Hosmer-Lemeshow test was applied to assess the goodness of fit of the model (GoF). It 
was considered satisfactory if the p-value was > 0.05. 
Receiver operating characteristic curves (ROC curves) for the age-adjusted main 
effect models were created and also visualised for men in Fig. 4. An ROC curve is a 
graph showing the relation between the sensitivity and specificity, where sensitivity is 
plotted against 1-specificity. The numerical value below the graph shows the area under 
the curve. A model estimating an area under the ROC curve of 0.5 has no predictive 
value at all. A value above 0.8 is considered to represent a good discrimination. The 
area under the ROC curve shows the model’s capacity to discriminate between those 
subjects who experience the outcome and those who do not. The positive and negative 
predictive values of the main effect models were analysed separately for men and 
women. 
Study IV 
Significant differences between proportions regarding categorical data and continuous 
data were analysed using the same statistical methods as in Studies I–III. The mortality 
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(percentage) and the mortality rate per 10,000 person-years were calculated for the 
depressed and non-depressed men and women. 
SMRs were calculated to compare the mortality rate of the depressed and non-
depressed men and women with that of the entire Swedish population of men and 
women (SMR = 1 = reference) aged 18–75, based on Life Tables for 2001–2010 from 
Statistics Sweden (146). First, the expected number of deaths for each 1-year age group 
was calculated. Second, the expected number of deaths for each 1-year age group was 
summed up for depressed and non-depressed men and women. Finally, SMR was 
calculated as the ratio between the observed number of deaths (O) and the expected 
number of deaths (E), thus SMR= O/E. 
Cox regression, adjusted for sex and age, was applied to estimate the hazard ratios 
(HRs) for mortality in relation to the explanatory variables: depression, socio-
demographic data, psychosocial factors, perceived physical health, smoking and 
alcohol use. Possible confounders/effect modifiers (socio-demographic data, 
psychosocial factors, smoking and alcohol use) were tested. 
A final main effect model, also adjusted for sex and age, was developed to identify 
the most powerful factors. 
A test of proportionality for the main effect model was performed and this 
assumption was satisfied. 
Interactions between depression and any of the included variables in the main effect 
model were tested. None was found. 
Survival curves were created to illustrate the mortality rate among depressed versus 
non-depressed patients. 
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RESULTS  
Study I  
Of the 135 participants 59 women, (44%) had a BDI score ≥ 10 (Fig. 1) and had a mean 
age of 45.3 years, not significantly differing from the 76 with BDI < 10. Fifty women 
(85%; mean age 48.5 years) performed the diagnostic interview. Those nine women 
(15%) who abstained from the interview were significantly younger (mean age 27.8) 
than the interviewed women.  
Among the women who accepted participation (n=143) and had BDI ≥ 10 the 
prevalence of depression was 24.5% (35/143). Out of the 35 identified women with 
depression ten women had already ongoing treatment with SSRI, whereas in 25 women 
the depression was not previously detected. 
The severity of depression according to MADRS was mild in 43% and moderate in 
53%. One woman had a severe depression. The MADRS score ranged from 7–35, with 
a mean value of 20, and the interquartile range (IQR) was 16-24. 
The only statistically significant difference in socio-demographic characteristics 
between the depressed women and the controls was that a higher proportion among 
depressed women had been sick-listed 14 days or longer compared to the controls (32% 
versus 11%) during the year before inclusion in the study (p=0.036). 
The depressed women mentioned at the index visit only mental symptoms 
significantly more often (22% versus 3%) than the controls ((p<0.0001). They 
mentioned mental symptoms combined with somatic symptoms significantly more 
often (69% versus 15%) than the controls (p<0.0001). One third of the depressed 
women mentioned only somatic symptoms. 
We found that the two-step method, when performed by the physicians, worked well 
for identifying depressed women, especially as the dropout rate was low in the second 
step compared to other studies (147, 148).  
Our hypothesis regarding detection of depressed women visiting the drop-in clinics 
was supported. Differences in socio-demographic and clinical characteristics were 
identified in the length of sick-listing period and in mentioning mental symptoms.  
Study II  
The prevalence of depression among the men in the opportunistic screening was 11%. 
Two thirds (63%) had a mild depression and about one third (35%) had a moderate 
depression, while one man had a severe depression. 
GS and BDI correlated well (r=0.80). Compared to the BDI, the screening with the 
GS overlooked five depressed men with mild depression. 
In addition, one of six among the participants reported an alcohol use of ≥ 15 
standard glasses per week, but no statistically significant difference was found between 
depressed and non-depressed men. 
In targeted screening the proportion of diagnosed depression (20/33 = 60.6%) was 
six times higher than in the opportunistic screening (14/190 = 10.5% = 11%).  
Our hypotheses were partly confirmed. We did not detect more cases of depression 
by screening with GS compared to screening with BDI; however, we found that 
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opportunistic screening was less effective than targeted screening in detecting men with 
depression.  
Study III  
Here, the participants were the men and women from both the opportunistic and the 
targeted screenings.  
In socio-demographic characteristics the only statistically significant difference was 
that the depressed men were unemployed to a higher extent than the non-depressed men. 
A strong association was found between depression and the psychosocial stressors 
in both men and women, with no gender difference. The three strongest psychosocial 
stressors associated with depression in the logistic regression models were in 
decreasing order: ‘being dissatisfied with one’s family situation’, ‘feeling very stressed’ 
and ‘perceiving poor physical health’. The ORs in the main effect models varied 
between 3.1 (95% CI: 1.4–6.6) and 22.4 (95 % CI: 5.8–86.8). The ROC values of the 
main effect model were 0.88 in men and 0.83 in women. The ROC curve among men is 
visualised in Fig. 4. The negative predictive values of the models in men were 90.7% 
and in women 76.5%.  
Also, dissatisfaction with one’s working situation had high ORs for being depressed, 
in men 13.2 (95% CI: 4.7–37.5) and women 32.5 (95% CI: 4.1–254.7).  
A gender difference was found regarding one of the lifestyle questions, as smoking 
was significantly more common in depressed men than in non-depressed men. For 
alcohol consumption no statistically significant difference was found between 
depressed and non-depressed men or between depressed and non-depressed women.  
Our hypothesis was only partly confirmed as the most powerful stressors were 
identical in men and women. 
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Figure 4. Receiver operating characteristics (ROC) curve visualising the probability 
among men of being depressed when having (or not having) the psychosocial stressors 
included in the logistic regression main effect model (dissatisfied with family situation, 
perceiving very stressed and perceiving one’s physical health as poor).  
 
Study IV  
The study population here was the same as in study III. 
The patients with mild or moderate depression at inclusion had an almost threefold 
mortality rate compared to the non-depressed patients during the 12-year follow-up 
period. This difference in mortality rate was significant only among men.  
The threefold higher risk of dying remained after adjustment for all other 
explanatory variables.  
The standardised mortality ratios did not significantly differ from those in the 
Swedish general population.  
Nearly one-quarter died of unnatural causes when alcohol-related liver disease was 
also included.  
Thus, our hypotheses were only partly confirmed; the depressed men had a higher 
mortality rate than their non-depressed counterparts, but there were no significant 
differences in the depressed men’s and women’s raised SMRs when compared by 
gender to the general population in Sweden. Also, nearly one quarter died of unnatural 
causes when alcohol-related liver disease was also included. 
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Figure 5. Survival curves from the age and sex-adjusted Cox regression main effect 
model showing survival among depressed and non-depressed patients during a 12 year 
follow-up. The upper curve = non-depressed patients. The lower curve = depressed 
patients. 
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ADDITIONAL RESULTS  
Symptoms mentioned by opportunistically screened men  
The women’s symptoms mentioned at the index visit were reported in Study I. Here we 
report the symptoms mentioned by opportunistically screened men, which were 
obtained in the same way as among the women. Low mood, anxiety, feelings of stress, 
sleeping problems or concentration problems, ruminating and fatigue were categorised 
as mental symptoms.  
 
Table 1. Symptoms mentioned among opportunistically screened men and women 
diagnosed with depression and non-depressed controls with BDI < 10. 
 Depressed men Depressed 
women 
Non-depressed 
men 
Non-depressed 
women 
N  23 32 177 76 
Symptoms  n %  n %  n %  n % 
Somatic only  16 70  10 31  145 82  65 85 
Mixed   3 13  15 47  25 14  9 12 
Mental only  4 17  7 22  7 4  2 3 
 
Mental symptoms, as a single symptom or combined with somatic symptoms, did not 
differ significantly between the depressed men and the non-depressed men.  
However, the depressed women mentioned statistically more frequent mental 
symptoms compared with depressed men (p=0.005, chi2). 
The most commonly mentioned mental symptoms among men were: sleeping 
problems, low mood, anxiety, feeling of stress and fatigue. Among the targeted 
screened men the most common mental symptoms mentioned were: sleeping problems 
and feeling stressed.  
Like among women the depressed men were sick-listed more than 14 days more 
frequently than the non-depressed men (38% versus 15%, p=0.001). 
Half of the opportunistically screened men had been sick-listed more than 14 days 
the year before the index visit compared to 17% among the controls (p=0.001).  
Among women in Study I the difference between depressed and controls was also 
significant (p=0.036).  
The total range of the MADRS scores among all the depressed men was 7–37, 
median 19 and IQR 14–22, which may be compared with the values among women 
with a total range of 7–35, median 20 and IQR 16–24. 
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DISCUSSION  
General comments  
Summary of the aims 
These studies aimed to elucidate major depression in a primary care setting with mostly 
good socio-demographic conditions with regard to the prevalence and severity of 
depression among men and women, and further to find possible clinical cues for 
detection, to shed light on gender-related psychosocial stressors and lifestyle factors, 
and lastly to explore long-term mortality among depressed men and women.  
Summary of results 
Major depressive disorder, mild or moderate, was detected in every fourth woman 
visiting this unscheduled drop-in clinic meant for quick consultations. Severe cases of 
depression were rare. Every tenth man was detected as having mostly mild depression, 
and these depressed men had reported fewer mental complaints than the depressed 
women.  
Detection of depression among patients was done using BDI in a two-step screening 
procedure by screening unselected patients and, in addition, by a screening targeted to 
those patients who mentioned mental symptoms; and in the second diagnostic step 
evaluate against the DSM-IV criteria for major depressive disorder, also including 
assessment of the severity with MADRS.  
Screening men with the Gotland Male Depression Scale did not increase detection 
of depression among men. The same three psychosocial risk factors – being dissatisfied 
with one’s family situation, feeling very stressed and perceiving one’s physical health 
as poor – were equally associated with depression among men and women. Finally, the 
mortality rate was higher among the depressed men visiting drop-in clinics than among 
the non-depressed but their standardised mortality rates did not differ statistically from 
that of the general population in Sweden.  
Evaluation of methods and results with regard to the time period 
Patients with burnout depression were categorised as depressed if they satisfied the 
criteria for MDD. The sampling of patients was performed during the years when sick-
listing increased rapidly in Sweden because of burnout syndrome. The criteria for these 
diagnoses were specified in 2003 and described to include specific symptoms of 
emotional exhaustion, rapid onset of cognitive dysfunction and rumination about 
working situation which separated them from depressed patients usually seen in 
psychiatric care (27). Notably, dissatisfaction with the work situation was common 
among the depressed men and women, and some of them might have been diagnosed 
today as burnout depression.  
Moreover, in the early 1990s there was a financial crisis affecting many public 
service institutions with many women employees, and women working in public sector 
that had been shown to be at risk of the ‘burnout syndrome’ (86). Such consequences 
might have influenced the prevalence found here. 
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Recently, a Swedish research group has identified biochemical markers for 
psychosocial stress in blood tests among women with burnout depression, and in the 
future it might be possible to identify these markers among women who are under 
prolonged psychosocial stress (149).  
Methods 
This project had a practice design, often labelled as action research, which is a research 
method derived from social research where the aim is to improve practice handling. It 
involves the actor and the person/patient/client (150). At that time many projects in 
primary care were organised using a similar research design (151, 152), and also later 
(153, 154). Its strength is its proximity to clinical practice, thus creating a sound 
pragmatic validity, while its limitations are due to its often single practice design and 
thus a reduced ability to generalise the results.  
Screening procedures 
The two-step screening method used here worked well with a low dropout rate in the 
second step when the patients’ own primary care physician had invited them to a repeat 
visit. By comparison, a higher dropout rate was shown in other studies where 
invitations to the repeat visits were made by a research team (147, 148). This showed 
confidence in the primary care physician and underlines the importance of continuity of 
care.  
Opportunistic screening 
There were several problems in using an opportunistic screening method.  
Here, a low cut-off score for the BDI was used in order to reach high sensitivity, but 
nearly one half of all women and one-fifth of the men had to be invited to the 
diagnostic interview. Today a higher cut-off score of ≥ 14 of BDI II is recommended by 
SBU (124). Using that cut-off value would have reduced the number of repeat visits, 
but some patients with mild depression would then have been missed.  
Using the GS did not catch more cases of depression among men. 
The BDI and GS with the cut-off scores used here were, as expected, not specific for 
depression; instead patients with other mental problems were detected but also these 
patients needed help, which is an important aspect to consider for primary care 
physicians.  
Some patients attend their primary care physicians often. It is not realistic to screen 
them at every visit, as we observed early in the project. A later review concluded that 
opportunistic screening for depression is not cost-effective in primary care (137).  
Targeted screening  
In order to reach the required number of patients, targeted screening was used among 
patients who had mentioned any mental problems, as only opportunistic screening of 
men would have taken very long time.  
Here, a patient-centred consultation was used by both the research doctors. In 
Denmark, the accuracy of the physicians’ ‘clinical suspicion’ of depression in patients 
has been shown to yield high ROC values; the method has been demonstrated to be 
more efficient than the screening programme recommended by the Danish National 
Board of Health (138). A patient-centred consultation model has been shown to have 
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lower sensitivity than the MADRS-S and PRIME-MD, resulting in fewer diagnostic 
interviews being required (155).  
Discussion of the results 
Prevalence and severity 
A meta-analysis of studies regarding diagnosed depression using data from 50,000 
primary care patients in 41 countries reported a prevalence of 20% (11% up to 23%), 
thus a prevalence in line with these results (156). However, the measured prevalence of 
depression depends largely on societal factors in the setting, the patients’ behaviours, 
and the health care organisation. The idea of the drop-in clinic was that it was the 
patients’ own decision to consult the physician with no barriers and without any 
restrictions or declaring their symptoms in advance.  
Here, the majority of the patients with depression were new cases. The prevalence 
was comparable to that found among multi-ethnic patients in Jordbro, a suburb of 
Stockholm (9), but higher than in a small town north-east of Stockholm (157). Among 
elderly patients in Gothenburg 15% had depressive symptoms according MADRS-S 
(158).  
Severe depressions in primary care patients were proven to be very rare also in 
studies from Sweden among immigrants with long-term disability and pain (159) and in 
Finland (6). However a higher prevalence of severe depression was identified in a 
Danish primary care study when ICD-10 criteria were used (160). 
Psychosocial stress and lifestyle  
Depression was previously categorised as endogenous or reactive but for a period the 
preceding factors for depression were scarcely debated. Reactive depression was seen 
as depressions following stressful events or losses. There is a renewed focus on societal 
determinants of depression (161).  
In our study, men and women had the same psychosocial stressors associated with 
depression, which facilitates using them as clinical cues, but above all as rule-out 
criteria for depression. Consequently, it seems that the stress linked to ‘double 
responsibilities’ of working life and family responsibilities among women (151) might 
also affect men today. This is also reflected in the general conceptions and the rules of 
the social security system in Sweden which stimulate fathers to take part in child care 
from the beginning. Whether relational stressors are important predicting factors in 
other settings as well, and in other countries, should be an interesting subject for future 
studies.  
In this setting, only a few men were unemployed, or smoked, yet they were more 
frequent among the depressed men. In general, alcohol use above the safe 
recommended limit was high among the men. Contrary to other research, there was 
thus no statistical evidence of association between excessive drinking and depression 
(76, 77).  
Patients with a burnout depression were included here among the depressed patients. 
It has since been shown that these patients often need multimodal treatment and their 
recovery takes a long time (162, 163).  
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Mortality  
Mortality rates among primary care patients with depression in Sweden have not been 
presented before. This cohort of depressed and non-depressed patients was followed up 
regarding mortality for 12 years. More depressed patients had died compared to the 
non-depressed. This difference was probably due to the fact that the healthy non-
depressed both men and women had very low SMRs, especially evident among the 
non-depressed men, thus these figures must be interpreted with precaution. 
Unnatural causes of death were found as well, but the interpretation is restricted 
since data on causes of death among the non-depressed patients were not analysed. This 
too should be subject for future studies. 
Patients with depression in primary care often have comorbid somatic and 
psychiatric diseases (6, 9); and depression has been found to be common among 
women with cardiovascular disease (164). In a Swedish population study, depression 
was identified as a risk factor for developing cardiac disease, in both men and women 
aged 25–50 years (165). An elevated risk of cardiovascular and coronary deaths has 
also been shown among depressed patients (166-168).  
Alcohol use  
The prevalence regarding alcohol use above safe limits is comparable to that in other 
Swedish primary care settings, where a study showed that half of the patients with 
harmful or hazardous alcohol use also had symptoms of depression and anxiety (169). 
Discussion of the methods  
Instruments used  
The BDI is regarded as one of the best-validated instruments for screening for 
depression, but a BDI with a higher cut-off score (≥ 14) than used here is recently 
recommended by SBU (133). A higher cut-off score would have reduced the number of 
repeat visits here, but some patients with mild depression would have been missed.  
The GS, including questions on changes in the use of alcohol and pills or intense 
working and sport activities, overlooked five cases of mild depression. Whether 
answers in these questions were associated with depression has not been analysed yet. 
Interestingly, some depressed men mentioned spontaneously that they found the GS 
questions concise and clear and ‘nailed it’ regarding their problem.  
MADRS has been shown to have high inter-rater correlation properties in primary 
care also among multicultural patients, and is a reliable method (159).  
The diagnostic process 
According to the exclusion criteria of MDD, somatic disease as reason for depression 
must be ruled out. The researchers met the depressed patients twice before the 
diagnosis, and systematically used the DSM-IV criteria. In addition, somatic 
examinations were also performed by the physicians to find and treat possible somatic 
reasons for the patients’ symptoms.  
Risk of over-diagnosis?  
Recently, a meta-analyses has reported on primary care physicians’ accuracy in 
detecting depression using unassisted screening – ‘gut-feeling’ (156). They found that 
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the number of patients misidentified as depressed was higher than the missed cases, but 
they were good at ruling out depression.  
It has been pointed out that there is risk of over-diagnosing when using DSM criteria 
since heavy dysfunction is not mandatory for the diagnosis of MDD (170). Also the 
book ‘Pillret’ reports on the history of how SSRI marketing in Sweden resulted in high 
prescription levels for depressed mood and anxiety (171).  
Correct diagnosis is the first step to good treatment. The ideal diagnostic process 
follows a methodology named LEAD (Longitudinal, Experts, All Data Procedure), 
described in detail in the SBU report (133). The method involves having all data, 
sometimes also from close family members, medical records, diagnostic interviews and 
the questionnaires are all evaluated by experts in a team. Such methods can be used in 
primary care in severe cases, when psychiatric specialists are consulted as well.  
Risk of under-diagnosis?  
To confirm the diagnosis of MDD, the patient’s symptoms must be evaluated against 
the diagnostic criteria in ICD-10 or DSM-IV. It is a problem for the physician to keep 
in mind the symptoms in MDD, while discussing the patient’s other treatments, and the 
risk of missed diagnosis is highest when comorbid somatic diseases are present (172). 
The questionnaires about depressive symptoms are helpful as the depressive symptoms 
are systematically registered. 
Here, the use of BDI seemed to facilitate discussion about the patients’ mental 
feelings. Patients’ depressed thoughts are made visible to the physicians and perhaps 
also to the patients in their answers. Discussing the answers also helped to keep the 
focus on mental problems, so often ‘pushed aside’ by other medical needs. 
An investigation conducted by the National Board of Health and Welfare found that 
today in Sweden about one quarter of primary care physicians always or sometimes use 
a questionnaire when investigating depression, and MADRS or MADRS-S were the 
most commonly used questionnaires (133).  
There might be a risk of missed diagnosis of depression among men since only a 
few of the men mentioned mental symptoms at least when visiting the drop-in clinic. 
Asking men about their social situation and stress proved to be important. 
Here the GS did not improve the detection rate.  
Strengths and limitations  
The major strength of this project is the action research design including two female 
specialists in primary care who involved their patients in their own practices with a low 
dropout rate. It resulted in new insights into screening and detection of depression in 
primary care practice as well as long-term mortality from a gender perspective. Another 
strong point is that the physicians met the depressed patients at least twice before the 
diagnosis, and that they continued caring for them. Furthermore, valid and reliable tools 
to diagnose depression and to assess the severity of depression were used and the 
studies also included lifestyle factors and alcohol questions.  
There are limitations such as reduced ability to generalise due to its single-site 
design, although the results should be possible to transfer to similar settings.  
Moreover, somatic diseases were not systematically recorded and the rate of 
possible depression among those patients having BDI or GS ratings below cut-off 
values were not assessed, preventing a calculation of predictive values. 
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CLINICAL IMPLICATIONS  
Patients who attend primary care physicians’ drop-in clinic have varying problems, 
ranging from common colds to serious diseases and depression is as prevalent among 
them as among other patients.  
For patients with comorbid diseases access to care with continuity is important, a 
drop-in clinic is only one form of access to the primary care physician.  
A possible cue for depression was identified when a patient mentioned mental 
symptoms. In this situation the physician would recommend further examination and 
use diagnostic instruments for depression. Primary care physicians can combine this 
with a physical check-up of the initial problems. 
Questions about family relations and other psychosocial stressors can be applied in 
almost all types of consultations, and can be used as an indicator of depression or as a 
rule-out question for depression, in men and women alike. 
Answering the BDI or other validated questionnaires for depression might be a 
signal to the patient that the physician is ready to discuss mental problems. In addition, 
answering for example the BDI might arouse the patients’ consciousness about their 
depressive thinking. Communication about depression between the patient and 
physician is thereby facilitated.  
Examination of depressed patients regarding somatic health and care of somatic 
diseases according to best practice is very important as they might have a risk for 
preterm death.  
Patients with e.g. diabetes and coronary heart disease comorbid with depression are 
high risk patients for preterm death and must be followed attentively.  
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CONCLUSIONS 
The prevalence and severity of depression was comparable to that in other primary care 
settings. Depressed women had often mentioned mental symptoms. Questions about 
family and working situation, feelings of stress and feelings about one’s physical health 
could be used as risk indicators for depression in clinical practice for both men and 
women. Moreover, the long-term follow-up results underline the importance of finding 
patients with depression and thoroughly examine them also regarding their somatic 
health.  
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FUTURE STUDIES 
It would be valuable to study further gender issues in diagnostics and detection of 
depression in different settings using multiple-site research centres, and also to study 
how men and women recognise depressive symptoms, e.g. by a qualitative design. 
Performing long-term studies on intervention methods for depression in primary care 
would be valuable, e.g. regarding outcome, sick-leave and mortality and mortality 
cause, comparing them to a non-depressed group and to those with multiple health 
problems.  
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SAMMANFATTNING PÅ SVENSKA 
SYFTEN  
Avhandlingens syften var att undersöka förekomsten och svårighetsgraden av 
depression hos oselekterade patienter på en ”drop-in” mottagning på en vårdcentral i 
centrala Stockholm samt att identifiera för depression typiska kliniska kännetecken, och 
att bedöma användbarheten av skattningsformulär. Dessutom undersöktes eventuella 
samband mellan depression, psykosociala stressfaktorer och livsstilsfaktorer i ett 
könsperspektiv och användbarheten av en ny skattningskala för depression bland män. 
Slutligen undersöktes i en långtidsuppföljning dödstalen bland de deprimerade 
patienterna jämfört med patienterna utan depression och svenska befolkningen. 
BAKGRUND  
Primärvårdspatienter har ofta många olika, både akuta och kroniska åkommor och 
samtidig förekomst av depression kan vara svår att upptäcka vid ett besök. Depression 
medför lidande och funktionsnedsättning för den som drabbas och stora kostnader för 
samhället och det är därför viktigt att upptäcka och behandla depression. 
Studier under 1990-talet hade visat att ungefär hälften av fallen med depression inte 
blev diagnostiserade vid ett givet tillfälle. Att förbättra upptäckten och diagnostiken av 
depression kändes särskilt angeläget under 1990-talet då de nya läkemedlen för 
behandling av depression, serotonin-återupptagshämmarna (SSRI), med färre 
biverkningar än tidigare läkemedel hade kommit ut på den svenska marknaden. 
Depression är känd som dubbelt så vanlig hos kvinnor som hos män. Låg 
socioekonomisk status är en känd riskfaktor för depression liksom negativa 
livshändelser, dålig kroppslig hälsa, relations- och alkoholproblem samt 
migrationsstress, men om riskfaktorerna var likartade för män och kvinnor var okänt. 
Självmord är vanligare bland män än bland kvinnor. Depression kan uttrycka sig på 
andra sätt hos män an hos kvinnor, vilket skulle kunna medföra att depression hos män 
lättare förbises av sjukvårdspersonalen. Förekomst av ”manlig depression” hade 
diskuterats som en möjlig faktor, inkluderande attacker av ilska, irritabilitet, sänkt 
impulskontroll, överaktivitet inom arbete eller idrott eller bruk av alkohol i lugnande 
syfte. En särskild skala hade därför utvecklats för att hitta män med depression 
”Gotlandsskalan för skattning av manlig depressivitet” (GS) där även sådana frågor 
ingår. Denna hade dock inte testats i primärvården. 
Studier hade också visat att patienter med hjärt-kärlsjukdom eller diabetes har högre 
dödlighet om de är deprimerade. Få långtidsstudier rapporterar om dödligheten bland 
deprimerade primärvårdspatienter. 
Diagnostik av depression och mätning av svårighetsgraden  
Diagnosen depression är i denna avhandling ställd enligt kriterierna i det psykiatriska 
diagnossystemet DSM-IV. Det centrala i kriteriet för depression (Major depression) är 
sänkt sinnesstämning och/eller oförmåga att känna glädje i kombination med minst fyra 
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andra symptom, till exempel initiativlöshet, sömnbesvär, koncentrationsstörning och 
mindervärdighetskänslor. 
Depressionens svårighetsgrad klassificeras som mild, måttlig eller svår. Vid mild 
depression orkar personen genomföra sina vanliga aktiviteter och vid svår depression 
har personen svårt att genomföra även vardagliga göromål och plågas av skuldkänslor 
och självmordstankar. Montgomery-Åsberg Depression Rating Scale (MADRS) 
används i klinisk verksamhet och forskning för skattningen av svårighetsgraden i ett 
depressivt tillstånd. 
PATIENTER OCH METODER 
Screeningsmetod för depression  
En ”tvåstegsmetod” användes för att hitta patienter med depression. Det innebar att 
patienter först svarade på frågor om depressiva symptom i ett screeningformulär. I 
nästa steg intervjuades de med poäng över ett tröskelvärde med syfte att avgöra om 
kriterierna för depression är uppfyllda. Metoden användes på två sätt: 1. för att screena 
alla patienter i målgruppen utan selektion (opportunistisk screening) eller 2. screening 
riktat till de patienter som hade tecken eller symtom som kan förekomma vid 
depression (riktad screening). 
Beck Depression Inventorium (BDI) (21 frågor, totalpoäng 0–63) har en hög 
känslighet vid screening av depression och innehåller frågor om depressiva symptom 
och tankemönster och användes för screening med tröskelvärdet BDI ≥ 10. Män 
screenades dessutom också med GS (13 frågor, totalpoäng 0–39) där tröskelvärdet ≥ 13 
användes. 
Övriga data  
Ett frågeformulär med sociala bakgrundsdata (SC) användes, där även frågor om 
stressfaktorer samt alkoholförbrukning och rökvanor ingick. 
Uppgifter om vilka symtom patienten angivit vid läkarbesöket erhölls från 
patientjournalen. De klassificerades som kroppsliga eller mentala. 
I Studie IV hämtades data från Socialstyrelsens dödsorsaksregister, 
Folkbokföringsregistret, och Statistiska centralbyrån. 
Målgrupp, procedur och diagnostik 
Målgruppen var patienter i åldern 18–75 år som sökte på två läkares (specialister i 
allmänmedicin) ”drop-in” mottagning på en vårdcentral i centrala Stockholm. Alla 
läkarna på vårdcentralen hade sin ”drop-in” mottagning varje dag mellan 10.00 och 
12.00, då patienterna kunde besöka sin husläkare utan föregående tidsbeställning. 
Rekryteringen av patienter till studien pågick mellan åren 1997 och 2001. 
En sjuksköterska frågade patienter i väntrummet om deltagande i studien 
(opportunistisk screening) och de som accepterade besvarade i frågorna i BDI, SC och 
GS och återlämnade dessa till sjuksköterskan före läkarbesöket. 
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De dagar då sjuksköterskan inte var på mottagningen tillfrågade läkarna själva de 
patienter som vid besöket på den öppna mottagningen visade tecken på eller uppgav 
symtom som kunde tyda på depression att delta i studien (riktad screening). Dessa 
deltagare besvarade frågorna i BDI, SC och GS efter besöket och skickade sedan 
formulären till husläkaren. 
Till diagnostisk intervju hos sin läkare enligt DSM-IV och MADRS kallades 
följande patienter: a) de med BDI ≥ 10, b) de med GS ≥ 13 samt c) de som angivit 
alkoholkonsumtion mätt i antal standardglas per vecka som kan innebära hälsorisk 
(män ≥ 15, kvinnor ≥ 10 standardglas). Vidare behandling och uppföljning planerades 
vid återbesöket. 
Kvinnor och män med BDI < 10 klassificerades som kontroller samt de som vid 
intervjun befanns vara friska. 
Studiepopulation i studierna I–IV  
Deltagare var de kvinnor och män som screenades enligt ovan som hade lämnat in 
godkända frågeformulär. Deras medelålder var 45,3 år (95 % konfidensintervall 43,9–
46,7). 
Studie I: Totalt 135 kvinnor från den oselekterade screeningen som svarade i BDI 
och SC.  
Studie II: Totalt 223 män, varav 190 från opportunistisk och 33 från riktad 
screening, som svarade i BDI, SC och GS. 
Studie III och Studie IV: Totalt 404 patienter, 235 män och 169 kvinnor, från både 
opportunistisk och riktad screening som svarade i BDI och SC. 
STATISTIK  
Skillnader mellan grupper analyserades med Chi 2 eller Fisher’s test. Logistisk 
regression användes för beräkning av riskkvoter (OR) för depression och för 
sammansatta riskfaktormodeller. Dödstal beräknades baserat på summan av observerat 
antal avlidna delat med varje individs risktid. Standardiserad dödlighet beräknades. 
Cox’s regression användes för att beräkna den relativa risken att dö under 
observationstiden på 12 år vid förekomsten av de förklarande variablerna, och 
uttrycktes i hasardkvoter (HR). 
RESULTAT  
Studie I 
Prevalensen av depression var 25 % bland de som initialt hade tackat ja till att delta i 
studien (n=43). Depressionen var mild i 43 % och måttlig i 53 %. Endast ett fall av svår 
depression identifierades. Ett kliniskt kännetecken var att flera deprimerade kvinnor än 
kontroller hade nämnt något psykiskt symtom vid det första besöket (69 % vs. 15 ; 
p<0,001). Vid det andra besöket identifierades även andra psykiska tillstånd, såsom 
krisreaktioner, och dessa kvinnor hade behov av och erbjöds hjälpinsatser. 
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Studie II 
Totalt 40 deprimerade män identifierades. Prevalensen av depression i den 
opportunistiska screeningen var 11 % och 61 % i den riktade screeningen. Mer än 
hälften av depressionerna var milda, resten var måttliga. Endast en man hade svår 
depression. Inga ytterligare män med depression identifierades vid screeningen med 
GS. Nästan var sjätte screenad man (18 %) angav en alkoholkonsumtion på en nivå 
som kan innebära hälsorisker (≥ 15 standardglas per vecka), men andelen 
högkonsumenter var inte högre bland de deprimerade än bland kontrollerna. 
Studie III 
Riskfaktormodellerna innehöll samma riskfaktorer för depression hos män och kvinnor 
och var (i fallande ordning): missnöje med familjesituationen, upplevd hög stressnivå 
och upplevd dålig fysisk hälsa. Oddskvoterna (OR) varierade mellan 3,1 (95 % CI: 1,4–
6,6) och 22,4 (95 % CI: 5, 8–86,8). Det negativa prediktiva värdet av modellen var 
90,7 % för män och 76,5 % för kvinnor. Missnöje med arbetssituationen hade förhöjd 
OR hos båda könen, män OR 13,2 (95 % CI: 4,7–37,5) och kvinnor OR 32,5 (95 % CI: 
4,1–254,7). Arbetslöshet och rökning var associerade med depression endast bland 
männen. 
Studie IV 
Flera av de deprimerade patienterna hade avlidit jämfört med de icke-deprimerade 
(11 % vs. 4 %) under observationstiden; sambandet var signifikant bara för männen 
(p=0,014). Dock hade de icke-deprimerade männen i vår studie en mycket låg 
dödlighet. De deprimerade patienternas standardiserade dödlighet skiljde sig inte 
signifikant från den svenska befolkningen. Den enda av de studerade variablerna som 
innebar signifikant förhöjd risk att avlida under observationstiden var att ha fått 
diagnosen depression, detta både som enskild faktor (HR 3,1 95 % CI 1,4–7,1) och i en 
sammansatt modell (HR 3,3; 95 % CI: 1,4–8,1). Onaturliga dödsorsaker, inberäknat 
självmord, oklar förgiftning och alkoholrelaterad leversjukdom förekom i ungefär en 
fjärdedel av alla dödsfall bland de deprimerade patienterna. 
Tidigare ej publicerat material  
Söksymptomen bland män i den opportunistiska screeningen granskades och 
grupperades på samma sätt som bland kvinnorna i Studie I. De deprimerade männen 
hade inte nämnt psykiska symptom oftare än de icke-deprimerade männen vid besöket. 
De deprimerade kvinnorna hade i signifikant högre grad nämnt något psykiskt 
symptom jämfört med deprimerade män (p=0,002). 
SLUTSATSER  
Eftersom studierna endast omfattar två läkares patienter är generaliserbarheten 
begränsad, men resultaten torde kunna överföras till liknande primärvårdspopulationer. 
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Var fjärde kvinna och var tionde man som sökte på den öppna mottagningen hade 
mild eller måttligt svår depression, med något enstaka undantag. Med GS identifierades 
inga ytterligare depressioner jämfört med screening med BDI. GS är dock det enda 
screeningsformuläret för depression som innehåller frågor om alkohol eller lugnande 
tabletter, en viktig fråga att ställa till patienter med depressiva symptom, oro och 
ångest. 
Screening riktad till patienter som nämnde mentala symtom fungerade bättre än att 
screena alla patienter. 
Tecken på depression hos kvinnor kunde identifieras i den kliniska bilden i att de 
oftare än icke-deprimerade hade nämnt psykiska symptom i den oselekterade 
screeningen; detta fann vi dock inte bland de deprimerade männen i motsvarande 
situation. 
Tre frågor, som lätt kan ställas vid patientmöten, nämligen frågor om patientens 
familje- och arbetssituation, självupplevd hälsa och upplevd stress, tycks kunna 
användas som indikatorer för förekomst av depression både hos män och kvinnor och 
torde fungera bättre än en oselekterad screening. Om dessa riskfaktorer inte föreligger 
hos män är sannolikheten liten att de har depression. 
Patienter med depression behöver följas upp noggrant avseende både kroppsliga 
sjukdomar och depression, eftersom de synes ha förhöjd risk att avlida. 
Att be patienten besvara ett frågeformulär om depression kan fungera som en signal 
till patienten att läkaren är beredd att diskutera även sådana symtom och samtalet kring 
patientens svar kan underlätta kommunikationen och diagnostiken av depression. Detta 
är dock ett ämne för fortsatta studier. 
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APPENDICES  
 
Major depressive disorder diagnostic criteria DSM-IV 
Major depressive disorder (MDD) is a mental diagnosis with defined symptoms in the 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). In 
MDD a combination of five mental symptoms have to be present most of the time for at 
least for two weeks. 
Depressed mood and feelings of worthlessness and hopelessness or absence of 
feelings of gladness are mandatory, and a combination of at least four additional 
symptoms is required to fill the criteria of MDD. Some exclusion criteria also have to 
be evaluated.  
List of symptoms in major depressive disorder  
Mandatory symptoms: Depressed mood or loss of interest and pleasure 
Together with at least four of the following seven symptoms:  
Weight loss 
Insomnia or hypersomnia 
Psychomotor agitation or retardation 
Fatigue or loss of energy 
Feelings of worthlessness or inappropriate guilt 
Diminished ability to think or concentrate or indecisiveness 
Recurrent thought of death, recurrent suicidal ideation 
 
Exclusion criteria are: 1. Criteria for mixed mania/depression are not fulfilled. 2. The 
symptoms result in suffering and decreased functions. 3. The symptoms are not a result 
of use of drugs, or medication, somatic illness or injury. 4. The symptoms are not better 
explained by grief. 
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Gotland Male Depression Scale (in this study)  
Har Du eller andra hos Dig under den senaste månaden märkt någon av följande 
beteendeförändringar som varken Du eller andra riktigt känner igen? 
 
 
1. Minskad stresstolerans / mer än vanligt lättstressad. 
 
 Inte alls 
 I viss mån 
 Stämmer rätt väl 
 Stämmer i hög grad 
 
2. Ökad aggressivitet, brusar lättare upp än vanligt, har ”kort stubin”. 
 Inte alls 
 I viss mån 
 Stämmer rätt väl 
 Stämmer i hög grad 
 
3. Känsla av utbrändhet och tomhet. 
 
 Inte alls 
 I viss mån 
 Stämmer rätt väl 
 Stämmer i hög grad 
 
4. Långvarig oförklarlig trötthet. 
 
 Inte alls 
 I viss mån 
 Stämmer rätt väl 
 Stämmer i hög grad 
 
5. Att du är mer lättirriterad, rastlös, missnöjd. 
 
 Inte alls 
 I viss mån 
 Stämmer rätt väl 
 Stämmer i hög grad 
 
6.  Att det är svårt att fatta även enkla vardagsbeslut. 
 
 Inte alls 
 I viss mån 
 Stämmer rätt väl 
 Stämmer i hög grad 
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7. Sömnrubbningar som t.ex: svårt att somna, vaknar många gånger under natten, 
vaknar för tidigt, sover för lite eller för mycket. 
 
 Inte alls 
 I viss mån 
 Stämmer rätt väl 
 Stämmer i hög grad 
 
8. Oro / ängslan / obehagskänsla framförallt på morgonen. 
 
 Inte alls 
 I viss mån 
 Stämmer rätt väl 
 Stämmer i hög grad 
 
9. Att du använder alkohol eller tabletter i lugnande och avkopplande syfte. 
 
 Inte alls 
 I viss mån 
 Stämmer rätt väl 
 Stämmer i hög grad 
 
10. Överaktivitet eller avreagering med hjälp av hetsigt och rastlöst idrottande, 
jogging eller arbete, för mycket / för lite ätande. 
 
 Inte alls 
 I viss mån 
 Stämmer rätt väl 
 Stämmer i hög grad 
 
11. Att du har blivit förändrad på ett sätt som gör att varken Du eller andra känner 
igen Dig eller tycker att Du är omöjlig att ha att göra med. 
 
 Inte alls 
 I viss mån 
 Stämmer rätt väl 
 Stämmer i hög grad 
 
12. Har Du känt Dig eller verkat dyster, negativ eller hopplös till sinnes, ”sett allt i 
svart”?  
 
 Inte alls 
 I viss mån 
 Stämmer rätt väl 
 Stämmer i hög grad 
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13. Har du själv känt eller andra lagt märke till ökande tendenser till självömkan, 
klagande, ”ynklighet”?  
  
 Inte alls 
 I viss mån 
 Stämmer rätt väl 
 Stämmer i hög grad 
 
14. Finns i Din ursprungsfamilj anlag för missbruk av alkohol, tabletter eller 
droger?  
 
 Ja 
 Nej 
 
15. Har det i din ursprungsfamilj förekommit anlag för nedstämdhet / depression 
eller självmordshandlingar?  
 
 Ja 
 Nej 
 
16. Har det i din ursprungsfamilj förekommit anlag för risksökande beteende eller 
”spelmani”?  
  
 Ja 
 Nej 
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